The 18 references in paper I. Shirinsky V., V. Shirinsky S., И. Ширинский В., В. Ширинский С. (2014) “ВЛИЯНИЕ ТЕРАПИИ СИМВАСТАТИНОМ НА ИММУНОЛОГИЧЕСКИЕ МАРКЕРЫ АТЕРОСКЛЕРОЗА У БОЛЬНЫХ РЕВМАТОИДНЫМ АРТРИТОМ // EFFECT OF SIMVASTATIN THERAPY UPON IMMUNOLOGICAL MARKERS OF ATHEROSCLEROSIS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS” / spz:neicon:mimmun:y:2011:i:1:p:101-104

1
Ширинский И.В., Желтова О.И., Ширинский В.С., Козлов В.А. Влияние симвастатина на активность болезни и содержание холестерина субфракций липопротеинов сыворотки крови у больных ревматоидным артритом // Терапевтический архив. – 2008. – No 3. – С. 63-65.
(check this in PDF content)
2
Насонов Е.Л. Иммунологические маркеры атеросклероза // Терапевтический архив. – 2002. – No 5. – С. 57-60.
(check this in PDF content)
3
Ребров А.П.,Воскобой И.П. Роль воспалительных и инфекционных факторов в развитии атеросклероза // Терапевтический архив. – 2004. – No 1. – С. 78-82.
(check this in PDF content)
4
Ширинский И.В., Желтова О.И., Соловьева Н.Ю., Ширинский В.С., Козлов В.А. Эффективность и безопасность симвастатина при ревматоидном артрите – открытое контролируемое исследование // Медицинская иммунология. – 2007. – No 4-5. – С. 477-482.
(check this in PDF content)
5
Gabriel S.E. Cardiovascular morbidity and mortality in rheumatoid arthritis // Am. J. Med. – 2008. – Vol. 121. – P. 9-14.
(check this in PDF content)
6
Gabriel S.E., Crowson C.S., Kremers H.M., Doran M.F., Turesson C., O’Fallon W.M., Matteson E.L. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years // Arthritis Rheum. – 2003. – Vol. 48. – P. 54-58.
(check this in PDF content)
7
Goodson N.J., Symmons D.P., Scott D.G., Bunn D., Lunt M., Silman A.J. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort // Arthritis Rheum. – 2005. – Vol. 52. – P. 2293-2299.
(check this in PDF content)
8
Harris T.B., Ferrucci L., Tracy R.P., Corti M.C., Wacholder S., Ettinger W.H., Jr., Heimovitz H., Cohen H.J., Wallace R. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly // Am. J. Med. – 1999. – Vol. 106. – P. 506-512.
(check this in PDF content)
9
Hedman A., Larsson P.T., Alam M., Wallen N.H., Nordlander R., Samad B.A. CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events? // Int. J. Cardiol. – 2007. – Vol. 120. – P. 108-114.
(check this in PDF content)
10
Mazer S.P., Rabbani L.E. Evidence for C-reactive protein’s role in (CRP) vascular disease: atherothrombosis, immuno-regulation and CRP // J. Thromb. Thrombolysis. – 2004. – Vol. 17. – P. 95105.
(check this in PDF content)
11
Nakou E.S., Liberopoulos E.N., Milionis H.J., Elisaf M.S. The role of C-reactive protein in atherosclerotic cardiovascular disease: an overview // Curr Vasc Pharmacol. – 2008. – Vol. 6. – P. 258-270.
(check this in PDF content)
12
Retterstol L., Eikvar L., Bohn M., Bakken A., Erikssen J., Berg K. C-reactive protein predicts death in patients with previous premature myocardial infarction – a 10 year follow-up study // Atherosclerosis. – 2002. – Vol. 160. – P. 433-440.
(check this in PDF content)
13
Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men // Circulation. – 2000. – Vol. 101. – P. 1767-1772.
(check this in PDF content)
14
Rye K.A., Barter P.J. Antiinflammatory actions of HDL: a new insight // Arterioscler. Thromb. Vasc. Biol. – 2008. – Vol. 28. – P. 1890-1891.
(check this in PDF content)
15
Shirinsky I.V., Zheltova O.I., Solovyova N.Y., Kozlov V.A., Shirinsky V.S. Changes in disease activity, cytokine production, and proliferation of peripheral blood mononuclear cells in patients with rheumatoid arthritis after simvastatin treatment // Scand. J. Rheumatol. – 2009. – Vol. 38. – P. 23-27.
(check this in PDF content)
16
Stoll G., Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization // Stroke. – 2006. – Vol. 37. – P. 1923-1932.
(check this in PDF content)
17
Doornum S., McColl G., Wicks I.P. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? // Arthritis Rheum. – 2002. – Vol. 46. – P. 862-873.
(check this in PDF content)
18
Gestel A.M., Prevoo M.L., van′t Hof M.A., van Rijswijk M.H., van de Putte L.B., van Riel P.L. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American
(check this in PDF content)